Potential Proton and Photon Dose Degradation in Advanced Head and Neck Cancer Patients by Intratherapy Changes

Overview

Journal J Appl Clin Med Phys

Specialties Biophysics
General Medicine

Date 2017 Sep 19

PMID 28921843

Citations 16

Authors

Kristin Stutzer

Annika Jakobi

Anna Bandurska-Luque

Steffen Barczyk

Carolin Arnsmeyer

Steffen Lock

Christian Richter

Affiliations

Soon will be listed here.

Abstract

Purpose: Evaluation of dose degradation by anatomic changes for head-and-neck cancer (HNC) intensity-modulated proton therapy (IMPT) relative to intensity-modulated photon therapy (IMRT) and identification of potential indicators for IMPT treatment plan adaptation.

Methods: For 31 advanced HNC datasets, IMPT and IMRT plans were recalculated on a computed tomography scan (CT) taken after about 4 weeks of therapy. Dose parameter changes were determined for the organs at risk (OARs) spinal cord, brain stem, parotid glands, brachial plexus, and mandible, for the clinical target volume (CTV) and the healthy tissue outside planning target volume (PTV). Correlation of dose degradation with target volume changes and quality of rigid CT matching was investigated.

Results: Recalculated IMPT dose distributions showed stronger degradation than the IMRT doses. OAR analysis revealed significant changes in parotid median dose (IMPT) and near maximum dose (D ) of spinal cord (IMPT, IMRT) and mandible (IMPT). OAR dose parameters remained lower in IMPT cases. CTV coverage (V ) and overdose (V ) deteriorated for IMPT plans to (93.4 ± 5.4)% and (10.6 ± 12.5)%, while those for IMRT plans remained acceptable. Recalculated plans showed similarly decreased PTV conformity, but considerable hotspots, also outside the PTV, emerged in IMPT cases. Lower CT matching quality was significantly correlated with loss of PTV conformity (IMPT, IMRT), CTV homogeneity and coverage (IMPT). Target shrinkage correlated with increased dose in brachial plexus (IMRT, IMPT), hotspot generation outside the PTV (IMPT) and lower PTV conformity (IMRT).

Conclusions: The study underlines the necessity of precise positioning and monitoring of anatomy changes, especially in IMPT which might require adaptation more often. Since OAR doses remained typically below constraints, IMPT plan adaptation will be indicated by target dose degradations.

Citing Articles

Proton Therapy Adaptation of Perisinusoidal and Brain Areas in the Cyclotron Centre Bronowice in Krakow: A Dosimetric Analysis.

Rydygier M, Skora T, Kisielewicz K, Spaleniak A, Garbacz M, Lipa M Cancers (Basel). 2024; 16(18).

PMID: 39335100 PMC: 11430589. DOI: 10.3390/cancers16183128.

CBCT-Based Dose Monitoring and Adaptive Planning Triggers in Head and Neck PBS Proton Therapy.

Reiners K, Dagan R, Holtzman A, Bryant C, Andersson S, Nilsson R Cancers (Basel). 2023; 15(15).

PMID: 37568697 PMC: 10417147. DOI: 10.3390/cancers15153881.

Evaluating the effect of setup uncertainty reduction and adaptation to geometric changes on normal tissue complication probability using online adaptive head and neck intensity modulated proton therapy.

Lalonde A, Bobic M, Sharp G, Chamseddine I, Winey B, Paganetti H Phys Med Biol. 2023; 68(11).

PMID: 37164020 PMC: 10351361. DOI: 10.1088/1361-6560/acd433.

Dosimetric impact of adaptive proton therapy in head and neck cancer - A review.

Huiskes M, Astreinidou E, Kong W, Breedveld S, Heijmen B, Rasch C Clin Transl Radiat Oncol. 2023; 39:100598.

PMID: 36860581 PMC: 9969246. DOI: 10.1016/j.ctro.2023.100598.

Advances in Image-Guided Radiotherapy in the Treatment of Oral Cavity Cancer.

Nien H, Wang L, Liao L, Lin P, Wu C, Shueng P Cancers (Basel). 2022; 14(19).

PMID: 36230553 PMC: 9561985. DOI: 10.3390/cancers14194630.

References

Cozzi L, Fogliata A, Lomax A, Bolsi A . A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol. 2001; 61(3):287-97. DOI: 10.1016/s0167-8140(01)00403-0. View

Barker Jr J, Garden A, Ang K, ODaniel J, Wang H, Court L . Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys. 2004; 59(4):960-70. DOI: 10.1016/j.ijrobp.2003.12.024. View

Lee N, Puri D, Blanco A, Chao K . Intensity-modulated radiation therapy in head and neck cancers: an update. Head Neck. 2005; 29(4):387-400. DOI: 10.1002/hed.20332. View

Popple R, Fiveash J, Brezovich I . Effect of beam number on organ-at-risk sparing in dynamic multileaf collimator delivery of intensity modulated radiation therapy. Med Phys. 2007; 34(10):3752-9. DOI: 10.1118/1.2779862. View

Hall W, Guiou M, Lee N, Dublin A, Narayan S, Vijayakumar S . Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2008; 72(5):1362-7. DOI: 10.1016/j.ijrobp.2008.03.004. View

van de Water T, Bijl H, Westerlaan H, Langendijk J . Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. Radiother Oncol. 2009; 93(3):545-52. DOI: 10.1016/j.radonc.2009.09.008. View

Castadot P, Lee J, Geets X, Gregoire V . Adaptive radiotherapy of head and neck cancer. Semin Radiat Oncol. 2010; 20(2):84-93. DOI: 10.1016/j.semradonc.2009.11.002. View

Bhide S, Davies M, Burke K, McNair H, Hansen V, Barbachano Y . Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. Int J Radiat Oncol Biol Phys. 2010; 76(5):1360-8. DOI: 10.1016/j.ijrobp.2009.04.005. View

Castadot P, Geets X, Lee J, Christian N, Gregoire V . Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation. Radiother Oncol. 2010; 95(2):209-17. DOI: 10.1016/j.radonc.2010.03.007. View

10.

Truong M, Nadgir R, Hirsch A, Subramaniam R, Wang J, Wu R . Brachial plexus contouring with CT and MR imaging in radiation therapy planning for head and neck cancer. Radiographics. 2010; 30(4):1095-103. DOI: 10.1148/rg.304095105. View

11.

van de Water T, Lomax A, Bijl H, de Jong M, Schilstra C, Hug E . Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2010; 79(4):1216-24. DOI: 10.1016/j.ijrobp.2010.05.012. View

12.

Zhao L, Wan Q, Zhou Y, Deng X, Xie C, Wu S . The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma. Radiother Oncol. 2010; 98(1):23-7. DOI: 10.1016/j.radonc.2010.10.009. View

13.

van de Water T, Bijl H, Schilstra C, Pijls-Johannesma M, Langendijk J . The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature. Oncologist. 2011; 16(3):366-77. PMC: 3228110. DOI: 10.1634/theoncologist.2010-0171. View

14.

Duma M, Kampfer S, Schuster T, Winkler C, Geinitz H . Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer. Strahlenther Onkol. 2012; 188(3):243-7. DOI: 10.1007/s00066-011-0041-8. View

15.

Zips D, Zophel K, Abolmaali N, Perrin R, Abramyuk A, Haase R . Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. Radiother Oncol. 2012; 105(1):21-8. DOI: 10.1016/j.radonc.2012.08.019. View

16.

Beltran M, Ramos M, Rovira J, Perez-Hoyos S, Sancho M, Puertas E . Dose variations in tumor volumes and organs at risk during IMRT for head-and-neck cancer. J Appl Clin Med Phys. 2012; 13(6):3723. PMC: 5718549. DOI: 10.1120/jacmp.v13i6.3723. View

17.

Kataria T, Sharma K, Subramani V, Karrthick K, Bisht S . Homogeneity Index: An objective tool for assessment of conformal radiation treatments. J Med Phys. 2013; 37(4):207-13. PMC: 3532749. DOI: 10.4103/0971-6203.103606. View

18.

Nishi T, Nishimura Y, Shibata T, Tamura M, Nishigaito N, Okumura M . Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer. Radiother Oncol. 2013; 106(1):85-9. DOI: 10.1016/j.radonc.2012.11.005. View

19.

Schwartz D, Garden A, Shah S, Chronowski G, Sejpal S, Rosenthal D . Adaptive radiotherapy for head and neck cancer--dosimetric results from a prospective clinical trial. Radiother Oncol. 2013; 106(1):80-4. DOI: 10.1016/j.radonc.2012.10.010. View

20.

Engelsman M, Schwarz M, Dong L . Physics controversies in proton therapy. Semin Radiat Oncol. 2013; 23(2):88-96. DOI: 10.1016/j.semradonc.2012.11.003. View